Effects of celecoxib in human retinoblastoma cell lines and in a transgenic murine model of retinoblastoma

Background/aim: Celecoxib, a cyclooxygenase-2 inhibitor and antiangiogenic agent, has demonstrated potent anticancer effects in preclinical studies and in human clinical trials. To evaluate the potential utility of this agent in the treatment of retinoblastoma, the authors investigated the effects o...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tong, C T, Howard, S A, Shah, H R, Van Quill, K R, Lin, E T, Grossniklaus, H E, O’Brien, J M
Médium: Artigo
Jazyk:Inglês
Vydáno: Copyright 2005 British Journal of Ophthalmology 2005
Témata:
Laboratory Science - Extended Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1772840/
https://ncbi.nlm.nih.gov/pubmed/16113385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2004.064915
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky